JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
PUT
S&P Global
SPGI
$114B
| $4.85M | ﹤0.01% |
11,000
+5,400
| +96% | +$2.13M |
2018 Q2
22 quarters
|
|
3002
CALL
BioMarin Pharmaceuticals
BMRN
$11.1B
| $4.84M | ﹤0.01% |
+50,200
| New | +$4.44M |
2023 Q4
0 quarters
|
|
3003
PUT
Deere & Co
DE
$185B
| $4.84M | ﹤0.01% |
12,100
+4,000
| +49% | +$1.51M |
2021 Q1
11 quarters
|
|
3004
CALL
Carnival Corporation Ltd
CCL
$34.6B
| $4.84M | ﹤0.01% |
260,900
-100,000
| -28% | -$1.45M |
2020 Q2
14 quarters
|
|
3005
Trustmark
TRMK
$2.67B
| $4.83M | ﹤0.01% |
173,316
+22,922
| +15% | +$531K |
2013 Q2
42 quarters
|
|
3006
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$752M
| $4.82M | ﹤0.01% |
30,098
+22,159
| +279% | +$3.3M |
2023 Q3
1 quarter
|
|
3007
Gentherm
THRM
$962M
| $4.82M | ﹤0.01% |
92,107
+16,072
| +21% | +$785K |
2014 Q3
37 quarters
|
|
3008
Empire State Realty Trust
ESRT
$722M
| $4.82M | ﹤0.01% |
497,694
+55,517
| +13% | +$481K |
2014 Q4
36 quarters
|
|
3009
Schneider National
SNDR
$5.77B
| $4.82M | ﹤0.01% |
189,218
+48,733
| +35% | +$1.2M |
2017 Q2
26 quarters
|
|
3010
Entravision Communication
EVC
$681M
| $4.81M | ﹤0.01% |
1,154,634
+85,216
| +8% | +$337K |
2017 Q1
27 quarters
|
|
|
LBRDA
3011
DELISTED
Liberty Broadband Class A
LBRDA
| $4.81M | ﹤0.01% |
59,635
-60,845
| -51% | -$5.1M |
2014 Q4
36 quarters
|
|
3012
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.83B
| $4.81M | ﹤0.01% |
177,791
+176,353
| +12,264% | +$4.49M |
2023 Q1
3 quarters
|
|
3013
CALL
Yum China
YUMC
$13.5B
| $4.81M | ﹤0.01% |
113,300
+10,400
| +10% | +$484K |
2023 Q3
1 quarter
|
|
3014
Treace Medical Concepts
TMCI
$286M
| $4.8M | ﹤0.01% |
376,653
+28,085
| +8% | +$284K |
2021 Q2
10 quarters
|
|
3015
Gerdau
GGB
$9.83B
| $4.8M | ﹤0.01% |
1,186,644
-1,725,678
| -59% | -$6.6M |
2013 Q2
42 quarters
|
|
3016
CALL
ScottsMiracle-Gro
SMG
$2.85B
| $4.78M | ﹤0.01% |
+75,000
| New | +$4.05M |
2023 Q4
0 quarters
|
|
3017
Medifast
MED
$131M
| $4.78M | ﹤0.01% |
71,105
-80,859
| -53% | -$5.63M |
2013 Q2
42 quarters
|
|
3018
Vanguard Russell 1000 ETF
VONE
$8.68B
| $4.78M | ﹤0.01% |
22,022
+8,220
| +60% | +$1.67M |
2015 Q4
32 quarters
|
|
|
LGF.A
3019
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $4.77M | ﹤0.01% |
437,786
+29,840
| +7% | +$272K |
2016 Q4
28 quarters
|
|
3020
YPF Sociedad Anonima ADS
YPF
$19.5B
| $4.77M | ﹤0.01% |
277,240
-28,694
| -9% | -$395K |
2018 Q4
20 quarters
|
|
3021
argenx
ARGX
$57.5B
| $4.76M | ﹤0.01% |
12,506
-11,111
| -47% | -$5.18M |
2020 Q3
13 quarters
|
|
3022
PUT
ClearShares Piton Intermediate Fixed Income ETF
PIFI
$95.3M
| $4.76M | ﹤0.01% |
250,000
+50,000
| +25% | +$4.52M |
2023 Q3
1 quarter
|
|
3023
Credit Acceptance
CACC
$5.48B
| $4.76M | ﹤0.01% |
8,928
-254
| -3% | -$114K |
2013 Q2
42 quarters
|
|
3024
Levi Strauss
LEVI
$7.65B
| $4.75M | ﹤0.01% |
287,441
+19,210
| +7% | +$285K |
2019 Q1
19 quarters
|
|
3025
CALL
Logitech
LOGI
$14.9B
| $4.75M | ﹤0.01% |
50,000
-200,500
| -80% | -$16.5M |
2022 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.